Table 1.
Clinical and demographic data | |
---|---|
Age | 52.6 ± 14.9 (27-84) |
Sex (women/men) | 37/57 |
Mean duration of pain (months) | 51.7 ± 21.4 (6-120) |
Mean pain intensity (VAS) | 6.7 ± 2.0 (4-10) |
Mean MQS | 10.1 ± 5.3 (1.0-25.0) |
Aetiology of neuropathic pain | |
Nerve trauma | 15 (15.9%) |
Post herpetic neuralgia | 20 (21.3%) |
Diabetic polyneuropathy | 6 (6.4%) |
Non-diabetic polyneuropathy | 5 (5.3%) |
Post-stroke pain | 4 (4.2%) |
Spinal cord trauma | 9 (9.5%) |
Plexus avulsion | 19 (20.2%) |
Trigeminal neuralgia | 4 (4.25%) |
Syringomyelia | 2 (2.1%) |
Leprosy associated neuropathic pain | 10 (10.6%) |
Medication use | |
Medication Quantification Score | 10.14 ± 5.96 |
Results are expressed in average ± standard deviation (range).